Overview

A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia

Status:
Completed
Trial end date:
2019-03-29
Target enrollment:
Participant gender:
Summary
A study to determine the maximum tolerated dose of an investigational drug in subjects with schizophrenia
Phase:
Phase 1
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride